IART - Integra LifeSciences Holdings Corporation
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 4.44B |
| Enterprise Value | 5.60B |
| Trailing P/E | 25.09 |
| Forward P/E | 15.48 |
| PEG Ratio (5 yr expected) | 1.56 |
| Price/Sales (ttm) | 2.91 |
| Price/Book (mrq) | 2.46 |
| Enterprise Value/Revenue | 3.58 |
| Enterprise Value/EBITDA | 20.93 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.15 |
| 52-Week Change 3 | -35.23% |
| S&P500 52-Week Change 3 | 3.90% |
| 52 Week High 3 | 61.66 |
| 52 Week Low 3 | 37.36 |
| 50-Day Moving Average 3 | 52.00 |
| 200-Day Moving Average 3 | 52.17 |
Share Statistics
| Avg Vol (3 month) 3 | 652.8k |
| Avg Vol (10 day) 3 | 1.56M |
| Shares Outstanding 5 | 81.9M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 70.82M |
| % Held by Insiders 1 | 13.09% |
| % Held by Institutions 1 | 94.60% |
| Shares Short (May 14, 2023) 4 | 2.93M |
| Short Ratio (May 14, 2023) 4 | 5.2 |
| Short % of Float (May 14, 2023) 4 | 4.11% |
| Short % of Shares Outstanding (May 14, 2023) 4 | 3.58% |
| Shares Short (prior month Apr 13, 2023) 4 | 3.18M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Jan 03, 2017 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2022 |
| Most Recent Quarter (mrq) | Mar 30, 2023 |
Profitability
| Profit Margin | 11.00% |
| Operating Margin (ttm) | 17.32% |
Management Effectiveness
| Return on Assets (ttm) | 4.56% |
| Return on Equity (ttm) | 10.45% |
Income Statement
| Revenue (ttm) | 1.56B |
| Revenue Per Share (ttm) | 18.92 |
| Quarterly Revenue Growth (yoy) | 1.10% |
| Gross Profit (ttm) | 982.03M |
| EBITDA | 390.26M |
| Net Income Avi to Common (ttm) | 171.88M |
| Diluted EPS (ttm) | 2.11 |
| Quarterly Earnings Growth (yoy) | -26.40% |
Balance Sheet
| Total Cash (mrq) | 323.03M |
| Total Cash Per Share (mrq) | 3.94 |
| Total Debt (mrq) | 1.61B |
| Total Debt/Equity (mrq) | 96.32 |
| Current Ratio (mrq) | 3.65 |
| Book Value Per Share (mrq) | 20.45 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 246.28M |
| Levered Free Cash Flow (ttm) | 212.63M |
© 2023 Yahoo. All rights reserved.